Clinical Trials Directory

Trials / Unknown

UnknownNCT05576402

Endoscopic Scoring System Utilization in Inflammatory Bowel Disease

Endoscopic Scoring System Utilization for Inflammatory Bowel Disease Activity Assessment

Status
Unknown
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Inflammatory bowel diseases comprise two distinctive entities: Crohn's disease and ulcerative colitis. During the last decade, endoscopic assessment of inflammation has become relevant since it is a prognostic factor. As a consequence, therapeutic targets now contemplate mucosal healing as part of the goals to be achieved. Endoscopic scores for Crohn's disease and ulcerative colitis have been developed to objectively assess the mucosal inflammatory activity. Although they may have some limitations, these scores have been widely accepted in referral centers, especially since they have been adopted as standard evaluation in inflammatory bowel disease clinical trials . However, their use in the setting of endoscopic practice outside centers with a high volume or with less experience in clinical trials is not known.

Conditions

Interventions

TypeNameDescription
PROCEDUREcolonoscopyendoscopic exploration of colonic mucosa to evaluate inflammatory activity in patients with either Crohn's disease or ulcerative colitis

Timeline

Start date
2022-05-02
Primary completion
2023-01-31
Completion
2023-02-20
First posted
2022-10-12
Last updated
2022-12-28

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT05576402. Inclusion in this directory is not an endorsement.